On treatment prediction of post-treatment sustained response to Peginterferon alfa-2a for HBeAg-negative Chronic Hepatitis B (CHB) patients using HBsAg and HBV DNA levels at weeks 12 and 24: PERSEAS cohort final results

dc.creator	Goulis, I.	en
dc.creator	Karatapanis, S.	en
dc.creator	Akriviadis, E. A.	en
dc.creator	Deutsch, M.	en
dc.creator	Dalekos, G. N.	en
dc.creator	Raptopoulou-Gigi, M.	en
dc.creator	Mimidis, K.	en
dc.creator	Germanidis, G.	en
dc.creator	Triantos, C. K.	en
dc.creator	Drakoulis, C.	en
dc.creator	Chounta, A.	en
dc.creator	Vafiadis, I.	en
dc.creator	Hatzis, G.	en
dc.creator	Gagalis, A.	en
dc.creator	Vlachogiannakos, J.	en
dc.creator	Zintzaras, E.	en
dc.creator	Koulouris, S.	en
dc.creator	Bakalos, G.	en
dc.creator	Papatheodoridis, G. V.	en
dc.date.accessioned	2015-11-23T10:28:51Z
dc.date.available	2015-11-23T10:28:51Z
dc.date.issued	2013
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/11615/28108
dc.source.uri	<Go to ISI>://WOS:000330252203182
dc.subject	Gastroenterology & Hepatology	en
dc.title	On treatment prediction of post-treatment sustained response to Peginterferon alfa-2a for HBeAg-negative Chronic Hepatitis B (CHB) patients using HBsAg and HBV DNA levels at weeks 12 and 24: PERSEAS cohort final results	en
dc.type	journalArticle	en

Αρχεία σε αυτό το τεκμήριο

Αρχεία	Μέγεθος	Τύπος	Προβολή
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.